Loading…
Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1
Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and...
Saved in:
Published in: | European journal of pediatrics 1990-06, Vol.149 (9), p.637-639 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763 |
---|---|
cites | cdi_FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763 |
container_end_page | 639 |
container_issue | 9 |
container_start_page | 637 |
container_title | European journal of pediatrics |
container_volume | 149 |
creator | Bain, M D Purkiss, P Jones, M Bingham, P Stacey, T E Chalmers, R A |
description | Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and quantitative differences between each of these metabolic parameters. Only when plasma tyrosine was kept in the low-normal range by strict phenylalanine restriction (10-15 mg phenylalanine/kg body weight) was detectable succinylacetone consistently eliminated from the urine. Urinary succinylacetone is the only measure of metabolite accumulation immediately proximal to the enzyme defect and its routine measurement will allow more effective control of dietary treatment. |
doi_str_mv | 10.1007/BF02034752 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79891036</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79891036</sourcerecordid><originalsourceid>FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMotVYv3oWcPAirM8l20xy1fkLBi56XJDtLI_tRN1mk_96UFj0N7_C8w_AwdolwiwDq7uEZBMhczcURm2IuRYagimM2TUvICtT6lJ2F8AUJ1riYsImQSiIWU2YePUUzbHkcyMSWusip8a3vTKTAw-ic77aNcRT7jng99C2Pa-Lj4FPsa274xkS_q_34uOZxO_Qhlan1JoUNcTxnJ7VpAl0c5ox9Pj99LF-z1fvL2_J-lTnUKmZ5ZWEhlUKBlFOFyoGqXK3AWAQDEqwg60AjFMIKmc-1tSioKIQQ2qlCztj1_u5m6L9HCrFsfXDUNKajfgyl0otUljvwZg-69GsYqC43g2-TgxKh3Pks_30m-OpwdbQtVX_oQaD8BT4qb-U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79891036</pqid></control><display><type>article</type><title>Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1</title><source>Springer Nature - Connect here FIRST to enable access</source><creator>Bain, M D ; Purkiss, P ; Jones, M ; Bingham, P ; Stacey, T E ; Chalmers, R A</creator><creatorcontrib>Bain, M D ; Purkiss, P ; Jones, M ; Bingham, P ; Stacey, T E ; Chalmers, R A</creatorcontrib><description>Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and quantitative differences between each of these metabolic parameters. Only when plasma tyrosine was kept in the low-normal range by strict phenylalanine restriction (10-15 mg phenylalanine/kg body weight) was detectable succinylacetone consistently eliminated from the urine. Urinary succinylacetone is the only measure of metabolite accumulation immediately proximal to the enzyme defect and its routine measurement will allow more effective control of dietary treatment.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/BF02034752</identifier><identifier>PMID: 2373116</identifier><language>eng</language><publisher>Germany</publisher><subject>Amino Acid Metabolism, Inborn Errors - diet therapy ; Female ; Heme - biosynthesis ; Heptanoates - urine ; Heptanoic Acids - urine ; Humans ; Infant ; Methionine - blood ; Phenylalanine - administration & dosage ; Tyrosine - blood</subject><ispartof>European journal of pediatrics, 1990-06, Vol.149 (9), p.637-639</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763</citedby><cites>FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2373116$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bain, M D</creatorcontrib><creatorcontrib>Purkiss, P</creatorcontrib><creatorcontrib>Jones, M</creatorcontrib><creatorcontrib>Bingham, P</creatorcontrib><creatorcontrib>Stacey, T E</creatorcontrib><creatorcontrib>Chalmers, R A</creatorcontrib><title>Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><description>Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and quantitative differences between each of these metabolic parameters. Only when plasma tyrosine was kept in the low-normal range by strict phenylalanine restriction (10-15 mg phenylalanine/kg body weight) was detectable succinylacetone consistently eliminated from the urine. Urinary succinylacetone is the only measure of metabolite accumulation immediately proximal to the enzyme defect and its routine measurement will allow more effective control of dietary treatment.</description><subject>Amino Acid Metabolism, Inborn Errors - diet therapy</subject><subject>Female</subject><subject>Heme - biosynthesis</subject><subject>Heptanoates - urine</subject><subject>Heptanoic Acids - urine</subject><subject>Humans</subject><subject>Infant</subject><subject>Methionine - blood</subject><subject>Phenylalanine - administration & dosage</subject><subject>Tyrosine - blood</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LAzEQhoMotVYv3oWcPAirM8l20xy1fkLBi56XJDtLI_tRN1mk_96UFj0N7_C8w_AwdolwiwDq7uEZBMhczcURm2IuRYagimM2TUvICtT6lJ2F8AUJ1riYsImQSiIWU2YePUUzbHkcyMSWusip8a3vTKTAw-ic77aNcRT7jng99C2Pa-Lj4FPsa274xkS_q_34uOZxO_Qhlan1JoUNcTxnJ7VpAl0c5ox9Pj99LF-z1fvL2_J-lTnUKmZ5ZWEhlUKBlFOFyoGqXK3AWAQDEqwg60AjFMIKmc-1tSioKIQQ2qlCztj1_u5m6L9HCrFsfXDUNKajfgyl0otUljvwZg-69GsYqC43g2-TgxKh3Pks_30m-OpwdbQtVX_oQaD8BT4qb-U</recordid><startdate>199006</startdate><enddate>199006</enddate><creator>Bain, M D</creator><creator>Purkiss, P</creator><creator>Jones, M</creator><creator>Bingham, P</creator><creator>Stacey, T E</creator><creator>Chalmers, R A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199006</creationdate><title>Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1</title><author>Bain, M D ; Purkiss, P ; Jones, M ; Bingham, P ; Stacey, T E ; Chalmers, R A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Amino Acid Metabolism, Inborn Errors - diet therapy</topic><topic>Female</topic><topic>Heme - biosynthesis</topic><topic>Heptanoates - urine</topic><topic>Heptanoic Acids - urine</topic><topic>Humans</topic><topic>Infant</topic><topic>Methionine - blood</topic><topic>Phenylalanine - administration & dosage</topic><topic>Tyrosine - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bain, M D</creatorcontrib><creatorcontrib>Purkiss, P</creatorcontrib><creatorcontrib>Jones, M</creatorcontrib><creatorcontrib>Bingham, P</creatorcontrib><creatorcontrib>Stacey, T E</creatorcontrib><creatorcontrib>Chalmers, R A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bain, M D</au><au>Purkiss, P</au><au>Jones, M</au><au>Bingham, P</au><au>Stacey, T E</au><au>Chalmers, R A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1</atitle><jtitle>European journal of pediatrics</jtitle><addtitle>Eur J Pediatr</addtitle><date>1990-06</date><risdate>1990</risdate><volume>149</volume><issue>9</issue><spage>637</spage><epage>639</epage><pages>637-639</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><abstract>Over an 18-month period serial observations of plasma tyrosine, methionine and urinary tyrosine metabolites were made and compared with urinary succinylacetone excretion in an infant with tyrosinaemia type 1 treated by diet alone. Despite broadly similar profiles there were significant temporal and quantitative differences between each of these metabolic parameters. Only when plasma tyrosine was kept in the low-normal range by strict phenylalanine restriction (10-15 mg phenylalanine/kg body weight) was detectable succinylacetone consistently eliminated from the urine. Urinary succinylacetone is the only measure of metabolite accumulation immediately proximal to the enzyme defect and its routine measurement will allow more effective control of dietary treatment.</abstract><cop>Germany</cop><pmid>2373116</pmid><doi>10.1007/BF02034752</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0340-6199 |
ispartof | European journal of pediatrics, 1990-06, Vol.149 (9), p.637-639 |
issn | 0340-6199 1432-1076 |
language | eng |
recordid | cdi_proquest_miscellaneous_79891036 |
source | Springer Nature - Connect here FIRST to enable access |
subjects | Amino Acid Metabolism, Inborn Errors - diet therapy Female Heme - biosynthesis Heptanoates - urine Heptanoic Acids - urine Humans Infant Methionine - blood Phenylalanine - administration & dosage Tyrosine - blood |
title | Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T16%3A38%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dietary%20treatment%20eliminates%20succinylacetone%20from%20the%20urine%20of%20a%20patient%20with%20tyrosinaemia%20type%201&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=Bain,%20M%20D&rft.date=1990-06&rft.volume=149&rft.issue=9&rft.spage=637&rft.epage=639&rft.pages=637-639&rft.issn=0340-6199&rft.eissn=1432-1076&rft_id=info:doi/10.1007/BF02034752&rft_dat=%3Cproquest_cross%3E79891036%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c197t-4db08377121e4ed17c07dcf70ab10a030b2ebc091062b23459bb12e662229c763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79891036&rft_id=info:pmid/2373116&rfr_iscdi=true |